The latest price target for Healthcare Realty Trust (NYSE:HR) was reported by Cantor Fitzgerald on February 17, 2026. The analyst firm set a price target for $21.00 expecting HR to rise to within 12 months (a possible 19.25% upside). 15 analyst firms have reported ratings in the last year.

The latest analyst rating for Healthcare Realty Trust (NYSE:HR) was provided by Cantor Fitzgerald, and Healthcare Realty Trust maintained their overweight rating.

The last upgrade for Healthcare Realty Trust Inc happened on October 20, 2025 when Wells Fargo raised their price target to $18. Wells Fargo previously had an underweight for Healthcare Realty Trust Inc.

The last downgrade for Healthcare Realty Trust Inc happened on September 15, 2025 when Raymond James changed their price target from N/A to N/A for Healthcare Realty Trust Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Realty Trust, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Realty Trust was filed on February 17, 2026 so you should expect the next rating to be made available sometime around February 17, 2027.

While ratings are subjective and will change, the latest Healthcare Realty Trust (HR) rating was a maintained with a price target of $19.00 to $21.00. The current price Healthcare Realty Trust (HR) is trading at is $17.61, which is out of the analyst’s predicted range.